Kara Lea Vine

16PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 16, 2026
Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy.

Samantha J Wade, Ashna A Kumar, Samuel O Nitschke

|Nov 10, 2025
Development of a targeted BioPROTAC degrader selective for misfolded SOD1.

Christen G Chisholm, Rachael Bartlett, Mikayla L Brown

|Nov 10, 2025
Localized Delivery of Anti-CD40/PD-1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a PDAC Mouse Model.

Elahe Minaei, Samantha J Wade, Chelsea Penney

|Mar 18, 2024
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.

Chloe Sligar, Ellie Reilly, Peter Cuthbertson

|Feb 10, 2024
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice.

Peter Cuthbertson, Amy Button, Chloe Sligar

|Apr 29, 2023
Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics.

Ashna A Kumar, Kara L Vine, Marie Ranson

Pageof 3

Frequent Collaborators

3 joint publications

Ronald Sluyter

2 joint publications

Darren N Saunders

2 joint publications

Therese M Becker

2 joint publications

Gary Tincknell